Eosinophil surface receptor EMR1: a novel therapeutic target for eosinophilic disorders

BACKGROUND: Although several novel agents are currently in clinical trials for eosinophilic disorders, none has demonstrated efficacy in reducing blood and tissue eosinophilia in all subjects. Additional approaches are clearly needed. OBJECTIVE: To explore the potential of the human eosinophil surfa...

Full description

Saved in:
Bibliographic Details
Main Authors: Legrand, Fanny, Tomasevic, Nenad, Simakova, Olga, Lee, Chyi-Chia Richard, Wang, Zengfang, Raffeld, Mark, Makiya, Michelle A., Palath, Varghese, Leung, John, Baer, Mark, Yarranton, Geoffrey, Maric, Irina, Bebbington, Christopher, Klion, Amy D.
Format: Artigo
Language:Inglês
Published: 2014
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4113341/
https://ncbi.nlm.nih.gov/pubmed/24530099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2013.11.041
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items